RECRUITING

Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma

Talk to us

Conditions

Basal Cell CarcinomaSuperficial Basal Cell CarcinomaNodular Basal Cell CarcinomaOptical coherence tomographyOCTLaser

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Optical coherence tomography guided laser treatment of basal cell carcinoma

Official Title

Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma

Quick Facts

Study Start:2021-01-13
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04744935

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 99 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Ability to understand and carry out subject instructions or be represented by a legally authorized guardian or representative
  2. * Ages 18 and older
  3. * Seeks and is scheduled for treatment of a BCC previously confirmed with biopsy
  1. * Inability to understand and/or carry out instructions
  2. * Patients with a BCC lesion that requires excision. This would include relatively large lesions (\>2.5 cm diameter), lesions that penetrate deep into the skin beyond the depth of the OCT image capture, high risk lesions as defined by the American Academy of Dermatology as recurrent and sclerosing subtype BCC, or metastases.
  3. * Patients with periocular BCCs which might expose the patient to risk of damage to eyes from the laser.
  4. * BCCs on legs due to their tendency towards poor wound healing.
  5. * Pregnancy
  6. * Patients unable to follow-up for the full 12 months.

Contacts and Locations

Study Contact

Feben Messele
CONTACT
949-824-5515
fmessele@hs.uci.edu

Principal Investigator

Christopher Zachary, MBBS FRCP
PRINCIPAL_INVESTIGATOR
University of California, Irvine

Study Locations (Sites)

UCI Health Gottschalk Medical Plaza
Irvine, California, 92617
United States

Collaborators and Investigators

Sponsor: Christopher Zachary

  • Christopher Zachary, MBBS FRCP, PRINCIPAL_INVESTIGATOR, University of California, Irvine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-01-13
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2021-01-13
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • Basal cell carcinoma
  • Superficial basal cell carcinoma
  • Nodular basal cell carcinoma
  • Optical coherence tomography
  • OCT
  • Laser

Additional Relevant MeSH Terms

  • Basal Cell Carcinoma
  • Superficial Basal Cell Carcinoma
  • Nodular Basal Cell Carcinoma